The Journal of Allergy and Clinical Immunology
Volume 120, Issue 6 , Pages 1382-1388 , December 2007

Impaired immune response to vaccinia virus inoculated at the site of cutaneous allergic inflammation

  • Jordan E. Scott, MD

      Affiliations

    • Department of Pediatrics, Division of Allergy and Immunology, Children's Hospital, Harvard Medical School, Boston, Mass
    • These authors contributed equally to this work.
    • ,
  • Abdallah ElKhal, PhD

      Affiliations

    • Department of Pediatrics, Division of Allergy and Immunology, Children's Hospital, Harvard Medical School, Boston, Mass
    • These authors contributed equally to this work.
    • ,
  • Eva-Jasmin Freyschmidt, PhD

      Affiliations

    • Department of Pediatrics, Division of Allergy and Immunology, Children's Hospital, Harvard Medical School, Boston, Mass
    • ,
  • Daniel H. MacArthur, BS

      Affiliations

    • Department of Pediatrics, Division of Allergy and Immunology, Children's Hospital, Harvard Medical School, Boston, Mass
    • ,
  • Douglas McDonald, MD, PhD

      Affiliations

    • Department of Pediatrics, Division of Allergy and Immunology, Children's Hospital, Harvard Medical School, Boston, Mass
    • ,
  • Michael D. Howell, PhD

      Affiliations

    • National Jewish Medical and Research Center, Denver, Colo
    • ,
  • Donald Y.M. Leung, MD, PhD

      Affiliations

    • National Jewish Medical and Research Center, Denver, Colo
    • ,
  • Amale Laouar, PhD

      Affiliations

    • Center for Blood Research, Institute for Biomedical Research, Harvard Medical School, Boston, Mass
    • ,
  • N. Manjunath, PhD

      Affiliations

    • Center for Blood Research, Institute for Biomedical Research, Harvard Medical School, Boston, Mass
    • ,
  • Teresa Bianchi, PhD

      Affiliations

    • Brigham and Women's Hospital and Department of Pediatrics and Dermatology, Harvard Medical School, Boston, Mass
    • ,
  • Marianne Boes, PhD

      Affiliations

    • Brigham and Women's Hospital and Department of Pediatrics and Dermatology, Harvard Medical School, Boston, Mass
    • ,
  • Hans C. Oettgen, MD, PhD

      Affiliations

    • Department of Pediatrics, Division of Allergy and Immunology, Children's Hospital, Harvard Medical School, Boston, Mass
    • ,
  • Raif S. Geha, MD

      Affiliations

    • Department of Pediatrics, Division of Allergy and Immunology, Children's Hospital, Harvard Medical School, Boston, Mass
    • Corresponding Author InformationReprint requests: Raif S. Geha, MD, Division of Immunology, Karp 10th floor, One Blackfan Street, Boston, MA 02115.

Received 9 April 2007 ,Revised 30 July 2007 ,Accepted 1 August 2007.

References 

  1. Esposito JJ, Fenner F. Poxviruses. In:  Knipe DM,  Howley PM editor. Fields virology. Philadelphia: Lippincott Williams & Wilkins; 2001;p. 2885–2922
  2. Lane JM, Ruben FL, Abrutyn E, Millar JD. Deaths attributable to smallpox vaccination, 1959 to 1966, and 1968. JAMA. 1970;212:441–444
  3. Neff JM, Lane JM, Fulginiti VA, Henderson DA. Contact vaccinia: transmission of vaccinia from smallpox vaccination. JAMA. 2002;288:1901–1905
  4. Lane JM, Millar JD. Risks of smallpox vaccination complications in the United States. Am J Epidemiol. 1971;93:238–240
  5. Shirasawa K, Akai K, Kawaguchi Y, Maeda S, Nagahara S, Toyoda H, et al. Widespread eczema vaccinatum acquired by contacts: a report of an autopsy case. Acta Pathol Jpn. 1979;29:435–455
  6. Marris E. Dramatic rescue relieves rare case of smallpox infection. Nat Med. 2007;13:517
  7. Leung DY, Bieber T. Atopic dermatitis. Lancet. 2003;361:151–160
  8. Karupiah G, Blanden RV, Ramshaw IA. Interferon gamma is involved in the recovery of athymic nude mice from recombinant vaccinia virus/interleukin 2 infection. J Exp Med. 1990;172:1495–1503
  9. Xu R, Johnson AJ, Liggitt D, Bevan MJ. Cellular and humoral immunity against vaccinia virus infection of mice. J Immunol. 2004;172:6265–6271
  10. Kohonen-Corish MR, King NJ, Woodhams CE, Ramshaw IA. Immunodeficient mice recover from infection with vaccinia virus expressing interferon-gamma. Eur J Immunol. 1990;20:157–161
  11. Sharma DP, Ramsay AJ, Maguire DJ, Rolph MS, Ramshaw IA. Interleukin-4 mediates down regulation of antiviral cytokine expression and cytotoxic T-lymphocyte responses and exacerbates vaccinia virus infection in vivo. J Virol. 1996;70:7103–7107
  12. van Den Broek M, Bachmann MF, Kohler G, Barner M, Escher R, Zinkernagel R, et al. IL-4 and IL-10 antagonize IL-12-mediated protection against acute vaccinia virus infection with a limited role of IFN-gamma and nitric oxide synthetase 2. J Immunol. 2000;164:371–378
  13. Spergel JM, Mizoguchi E, Brewer JP, Martin TR, Bhan AK, Geha RS. Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice. J Clin Invest. 1998;101:1614–1622
  14. Spergel JM, Mizoguchi E, Oettgen H, Bhan AK, Geha RS. Roles of TH1 and TH2 cytokines in a murine model of allergic dermatitis. J Clin Invest. 1999;103:1103–1111
  15. Laouini D, Elkhal A, Yalcindag A, Kawamoto S, Oettgen H, Geha RS. COX-2 inhibition enhances the TH2 immune response to epicutaneous sensitization. J Allergy Clin Immunol. 2005;116:390–396
  16. Phelps AL, Gates AJ, Hillier M, Eastaugh L, Ulaeto DO. Comparative efficacy of modified vaccinia Ankara (MVA) as a potential replacement smallpox vaccine. Vaccine. 2007;25:34–42
  17. In:  Earl PL,  Cooper N,  Wyatt LS,  Moss B,  Carroll MW editor. Preparation of cell cultures and vaccinia virus stocks. Mississauga, Ontario, Canada: John Wiley & Sons, Inc; 1998;
  18. Freyschmidt EJ, Mathias CB, Macarthur DH, Laouar A, Narasimhaswamy M, Weih F, et al. Skin inflammation in RelB(-/-) mice leads to defective immunity and impaired clearance of vaccinia virus. J Allergy Clin Immunol. 2007;119:671–679
  19. Elkhal A, Pichavant M, He R, Scott J, Meyer E, Goya S, et al. CD1d restricted natural killer T cells are not required for allergic skin inflammation. J Allergy Clin Immunol. 2006;118:1363–1368
  20. Ennis FA, Cruz J, Demkowicz WE, Rothman AL, McClain DJ. Primary induction of human CD8+ cytotoxic T lymphocytes and interferon-gamma-producing T cells after smallpox vaccination. J Infect Dis. 2002;185:1657–1659
  21. Huang S, Hendriks W, Althage A, Hemmi S, Bluethmann H, Kamijo R, et al. Immune response in mice that lack the interferon-gamma receptor. Science. 1993;259:1742–1745
  22. Snapper CM, Paul WE. Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science. 1987;236:944–947
  23. Howell MD, Jones JF, Kisich KO, Streib JE, Gallo RL, Leung DY. Selective killing of vaccinia virus by LL-37: implications for eczema vaccinatum. J Immunol. 2004;172:1763–1767
  24. Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med. 2002;347:1151–1160
  25. Howell MD, Gallo RL, Boguniewicz M, Jones JF, Wong C, Streib JE, et al. Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus. Immunity. 2006;24:341–348
  26. Davidson DJ, Currie AJ, Reid GS, Bowdish DM, MacDonald KL, Ma RC, et al. The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization. J Immunol. 2004;172:1146–1156
  27. van den Broek MF, Muller U, Huang S, Zinkernagel RM, Aguet M. Immune defence in mice lacking type I and/or type II interferon receptors. Immunol Rev. 1995;148:5–18
  28. Manetti R, Annunziato F, Tomasevic L, Gianno V, Parronchi P, Romagnani S, et al. Polyinosinic acid: polycytidylic acid promotes T helper type 1-specific immune responses by stimulating macrophage production of interferon-alpha and interleukin-12. Eur J Immunol. 1995;25:2656–2660
  29. Wollenberg A, Wagner M, Gunther S, Towarowski A, Tuma E, Moderer M, et al. Plasmacytoid dendritic cells: a new cutaneous dendritic cell subset with distinct role in inflammatory skin diseases. J Invest Dermatol. 2002;119:1096–1102
  30. Guttman-Yassky E, Lowes MA, Fuentes-Duculan J, Whynot J, Novitskaya I, Cardinale I, et al. Major differences in inflammatory dendritic cells and their products distinguish atopic dermatitis from psoriasis. J Allergy Clin Immunol. 2007;119:1210–1217
  31. Karupiah G, Xie QW, Buller RM, Nathan C, Duarte C, MacMicking JD. Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase. Science. 1993;261:1445–1448
  32. Hogg KG, Kumkate S, Anderson S, Mountford AP. Interleukin-12 p40 secretion by cutaneous CD11c+ and F4/80+ cells is a major feature of the innate immune response in mice that develop Th1-mediated protective immunity to Schistosoma mansoni. Infect Immun. 2003;71:3563–3571
  33. Barton D, HogenEsch H, Weih F. Mice lacking the transcription factor RelB develop T cell-dependent skin lesions similar to human atopic dermatitis. Eur J Immunol. 2000;30:2323–2332

 Supported by federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under contract number HHSN266200400030C (Atopic Dermatitis Vaccinia Network).

 Disclosure of potential conflict of interest: J. Scott has consulting arrangements with Alicare Medical Management, owns Pharmaceutical holder trust stock, and is on the speakers' bureau for Verus Pharmaceuticals. The rest of the authors have declared that they have no conflict of interest.

PII: S0091-6749(07)01457-1

doi: 10.1016/j.jaci.2007.08.004

The Journal of Allergy and Clinical Immunology
Volume 120, Issue 6 , Pages 1382-1388 , December 2007

Article Tools

* Image Usage & Resolution